Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Alexion Pharmaceuticals Inc (NASDAQ:ALXN)

127.22
Delayed Data
As of Sep 23
 -6.47 / -4.84%
Today’s Change
110.56
Today|||52-Week Range
193.45
-33.31%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2015
Quarter 4
2015
Quarter 1
2016
Quarter 2
2016
Revenue and IncomeNet Revenues637.1M700.9M678.2M737.4M
 
 
 
 
 
Cost of Goods Sold45.7M43.8M42.3M42.9M
 
 
 
 
 
Depreciation And Amortization49.7M93.8M96.8M97.8M
 
 
 
 
 
 
Operating ExpensesGross Income541.7M563.3M539.1M596.8M
 
 
 
 
 
General Expenses373.5M432.6M408.9M411.1M
 
 
 
 
 
Research And Development161.0M191.0M176.3M179.3M
 
 
 
 
 
Total Operating Expenses468.8M570.2M547.9M551.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income168.3M130.7M130.3M185.6M
 
 
 
 
 
Extraordinary Credit0.000.0014.8M--
 
 
Extraordinary Charge-43.2M-33.3M-2.1M-6.6M
 
 
 
 
 
Interest Expense On Debt20.0M23.2M23.9M23.8M
 
 
 
 
 
Other Expenses32.3M-1.1M22.6M13.0M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income139.4M74.5M143.6M170.0M
 
 
 
 
 
Income Taxes-323.1M-7.9M-51.4M-55.0M
 
 
 
 
 
Net Income-183.8M66.6M92.2M114.9M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS226.2M225.5M225.1M224.1M
 
 
 
 
 
Shares To Calculate EPS Diluted226.2M228.0M226.9M225.8M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.81$0.29$0.41$0.51
 
 
 
 
 
EPS Diluted-$0.81$0.29$0.41$0.51